Slingshot members are tracking this event:
U.S. FDA expands indication for type 2 diabetes treatment Synjardy (empagliflozin/metformin hydrochloride) to include treatment-naïve adults
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Jul 19, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Synjardy, Type 2 Diabetes, Empagliflozin, Metformin Hydrochloride, Treatment-naive Adults, Lactic Acidosis, Buildup Of Lactic Acid In The Blood, Synjardy